Case Comprehensive Cancer Center: Myelodysplastic-Myeloproliferative Diseases trials
The registry lists 13 Myelodysplastic-Myeloproliferative Diseases studies with Case Comprehensive Cancer Center as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 9Phase 3 1No phase 2(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT01093586Phase 2Results posted
- Donor Stem Cell Transplant in Treating Patients With Hematologic CancerCompletedNCT00054327Phase 2Results posted
- Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialCompletedNCT00750009Phase 3
- Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationCompletedNCT00281801
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative DisorderCompletedNCT00274820Phase 2
- Campath-1H + FK506 and Methylprednisolone for GVHDCompletedNCT00109993Phase 2
- Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic MalignanciesCompletedNCT00068523Not applicable
- Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic AnemiaCompletedNCT00054236Phase 1
- Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDSCompletedNCT00053287Phase 2
- Non-Ablative Allo HSCT For Hematologic Malignancies or SAACompletedNCT00006379Phase 2
- Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic ConditionsCompletedNCT00003336Phase 2
- Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerCompletedNCT00003335Phase 2
- High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2